Home › Thyroid Cancer › NCT04742608
Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Isolation and Characterization of Extracellular Vesicles in Patients With Thyroid Nodules and Thyroid Cancer
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Aged 18 and older * Consented for thyroid surgery for thyroid cancer or indeterminate thyroid nodule Exclusion Criteria: * Patients with concurrent malignancy
About the study
This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.
What is being tested
- Biospecimen Collection (procedure)
- Electronic Health Record Review (other)
Sponsor: Jonsson Comprehensive Cancer Center · Participants: 250 · Started: Feb 21, 2020
Contact the study team
Official record on ClinicalTrials.gov — NCT04742608
Locations in the U.S.
| California | UCLA / Jonsson Comprehensive Cancer Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.